August 24, 2016 2:38 AM ET

Life Sciences Tools and Services

Company Overview of Prolexys Pharmaceuticals, Inc.

Executive Profile

Sudhir R. Sahasrabudhe Ph.D.

Scientific Founder, Acting Chief Executive Officer, Chief Scientific Officer and Director, Prolexys Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Dr. Sudhir R. Sahasrabudhe, Ph.D., is the Scientific Founder of Prolexys Pharmaceuticals, Inc. and serves as its Acting Chief Executive Officer and Chief Scientific Officer. Dr. Sahasrabudhe served as Chief Scientific Officer and Director of Myriad Proteomics and its scientific founder. Most recently, he served as Executive Vice President for Research and Development of Myriad Genetics since July 2000. At Myriad Genetics, Dr. Sahasrabudhe was responsible for managing ...

Corporate Headquarters

2150 West Dauntless Avenue (1000 North)
Salt Lake City, Utah 84116

United States

Phone: 801-303-1700
Fax: 801-303-1701

Board Members Memberships

Scientific Founder, Acting Chief Executive Officer, Chief Scientific Officer and Director


Doctorate 1987
Maharaja Sayajirao University of Baroda
Maharaja Sayajirao University of Baroda
Maharaja Sayajirao University of Baroda

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Prolexys Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at